At CPHI Frankfurt 2025, Amcor will unveil its latest packaging innovations for the pharmaceutical industry, with a particular focus on solutions designed for the rapidly growing biologics market.
The company’s presence at one of the world’s leading pharmaceutical events underscores how packaging is evolving to meet the new challenges of biologics manufacturing and sustainable healthcare.
As a global leader in responsible packaging, Amcor will present a range of technologies that reflect the dual priorities shaping today’s pharma sector: patient safety and environmental performance. High-barrier materials, recyclable laminates, and lightweight flexible structures are at the core of the company’s approach to improving product protection while reducing carbon footprint. These solutions are designed to maintain drug stability throughout the cold chain, a crucial requirement for biologics, which are often temperature-sensitive and complex to handle.
The biologics segment continues to expand at an exceptional rate, driving new expectations for packaging that ensures integrity and compliance under strict regulatory standards. Advanced material science, optimized sealing systems, and improved moisture and oxygen barriers are enabling a new generation of packs that combine functional safety with circular design. For pharmaceutical manufacturers, such developments translate into greater efficiency and alignment with both EMA and FDA sustainability guidelines.
Beyond individual product innovations, Amcor’s participation at CPHI highlights a broader movement within the industry. The event increasingly serves as a platform for collaboration between packaging producers, drug developers, and supply chain partners aiming to reduce waste, enhance traceability, and accelerate the transition to recyclable or bio-based materials. These initiatives reflect a shared understanding that sustainability in pharma cannot rely solely on product innovation but it requires systemic change and collective responsibility.
Through these efforts, Amcor reinforces its long-standing commitment to innovation and sustainability, building on decades of expertise in primary and secondary packaging for the global pharmaceutical market. CPHI Frankfurt 2025 once again stands out as the key platform to discover how packaging innovation is shaping the future of the pharmaceutical and biologics industry where performance, compliance, and responsibility converge.
